Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2012 08:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Achieves a 2012 Goal by Filing Two ANDAs -- Generic Forms of Keppra XR(R) and Pristiq(R)

TORONTO, Sept. 5, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
July 31, 2012 08:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Settles Patent Litigation With AstraZeneca Concerning Generic Seroquel XR(R)

TORONTO, July 31, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
July 03, 2012 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Second Quarter 2012 Results

TORONTO, July 3, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
May 01, 2012 07:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Meets a 2012 Goal for Abuse-Deterrent Oxycodone

TORONTO, May 1, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
April 12, 2012 20:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces First Quarter 2012 Results

TORONTO, April 12, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 27, 2012 08:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Webcast of Presentation at the 11th Annual Needham Healthcare Conference

TORONTO, March 27, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 15, 2012 17:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Closes US$5,000,000 Registered Direct Offering of Common Shares

TORONTO, March 15, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI)(TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
March 09, 2012 09:12 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Raise US$5 Million

TORONTO, March 9, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
February 17, 2012 08:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics to Present at Upcoming Cowen Healthcare and Roth Conferences

TORONTO, Feb. 17, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
February 08, 2012 09:15 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces 2011 Year End Results

TORONTO, Feb. 8, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...